Although ROS was produced in cancer cells irrespective of pathological grade or stage, immunohistochemistry showed high expression of NOX1 proteins in high-grade, superficially, and deeply invasive carcinomas (pT1 and > pT2), as well as in carcinoma in situ, but not in low-grade and non-invasive phenotypes (pTa). The gene discussed is NOX1; the disease is carcinoma.